TB-500 Dosing Protocol: 5 mg Vial — Loading & Maintenance Schedule

TB-500 Dosing Protocol: 5 mg Vial — Loading & Maintenance Schedule

Quickstart highlights

TB-500 is a synthetic peptide corresponding to the active fragment (Ac-SDKP, 17 amino acids from the C-terminus) of Thymosin Beta-4 — a 43-amino acid actin-sequestering protein ubiquitous in human tissue.

  • Concentration: 2 mg/mL (5 mg vial + 2.5 mL bacteriostatic water).
  • At 2 mg/mL: 2 mg = 100 units on a U-100 syringe.
  • Loading phase: 2 mg 2x weekly for 4–6 weeks; maintenance: 2 mg every 2 weeks.
  • TB-500 acts systemically — inject in abdomen, not at injury site.
  • One 5 mg vial provides ~2.5 loading doses (2 mg each); plan 4 vials for a 6-week loading phase.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-62000100Twice weekly2 mg 2x weekly — 100 units each; loading phase; one 5 mg vial provides ~2.5 injections
7+2000100Every 2 weeks2 mg every 2 weeks — maintenance phase; one 5 mg vial provides 2 maintenance doses

Gradual approach

WeekDose (µg)UnitsNotes
1-81000501 mg 2x weekly — conservative loading; suitable for sensitive patients or first TB-500 cycle
9-122000100Advance to 2 mg 2x weekly if 1 mg well-tolerated

Your free TB-500 tracker

  • Dose reminders
  • Injection logging
  • Cycle progress
Add your listing Already have one? Sign in

Reconstitution steps

  1. Draw 2.5 mL bacteriostatic water; inject slowly down the vial wall.
  2. Swirl gently until lyophilized powder dissolves; do not shake — TB-500 is susceptible to degradation from mechanical agitation.
  3. Final concentration: 2 mg/mL. At 2 mg/mL: 2 mg = 100 units on a U-100 syringe.
  4. Label with date; refrigerate at 2–8 °C. Use within 28 days.

Supplies needed

8-week plan

  • 4 vials
  • 16 syringes
  • 10 mL bac water
  • 16 alcohol swabs

12-week plan

  • 7 vials
  • 24 syringes
  • 18 mL bac water
  • 24 alcohol swabs
Need clinics? See vetted providers →
Advertisement

Protocol overview & cycle notes

Promote systemic tissue repair, reduce inflammation, and accelerate injury recovery through the TB-500 loading-then-maintenance protocol, leveraging Thymosin Beta-4's unique actin-sequestering and stem cell-mobilizing properties.

Cycle length: 12 weeks on.

Off-cycle: 4–8 weeks off after 12-week cycle.

Storage & handling

Lyophilized: store below 25 °C (or refrigerate). Reconstituted at 2 mg/mL: refrigerate 2–8 °C; use within 28 days. TB-500 is a larger peptide than BPC-157 — handle gently; avoid shaking or vortexing.

Injection & tracking tips

  • TB-500 has systemic effects unlike BPC-157 — injection site does not need to be near the injury; abdomen is preferred for reliable subcutaneous absorption.
  • Do not shake the reconstituted vial; TB-500 (as a fragment of the 43-amino acid Thymosin Beta-4) is more prone to mechanical degradation than smaller peptides.
  • For combination with BPC-157: use separate syringes and separate injection sites; TB-500 and BPC-157 can be used on the same days.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • Track injury pain (0–10 VAS) and range of motion weekly during loading phase.
  • Log systemic effects: fatigue levels, exercise recovery, and any soft tissue inflammation indicators.
  • Measure inflammatory markers (CRP, ESR) at baseline and after 6 weeks if clinically indicated.
Log your cycle in the calculator →

How this works & references

TB-500 is a synthetic peptide corresponding to the active fragment (Ac-SDKP, 17 amino acids from the C-terminus) of Thymosin Beta-4 — a 43-amino acid actin-sequestering protein ubiquitous in human tissue. TB-500's tissue repair mechanisms include: (1) G-actin sequestration promoting cell migration and cytoskeletal organization; (2) upregulation of cell surface receptor LIMS1 (LIM domain) for stem cell mobilization; (3) BMP-4 and Wnt pathway activation for cardiac and blood vessel repair (Bock-Marquette et al., 2004). Unlike BPC-157, TB-500 acts systemically rather than locally and does not require injection at the injury site.

Frequently asked questions

What is the difference between TB-500 and Thymosin Beta-4?
Thymosin Beta-4 (Tβ4) is the full 43-amino acid protein; TB-500 is the active fragment corresponding to amino acids 17–23 of Tβ4 (Ac-LKKTETQ in some definitions, though commercial 'TB-500' typically refers to the entire peptide sequence used in veterinary and research studies). The therapeutic properties of the commercially available TB-500 mimic those of full Tβ4 in animal models.
Should I inject TB-500 near the injury, like BPC-157?
No — this is a key distinction. TB-500 works systemically via bloodstream-mediated mechanisms (stem cell mobilization, systemic actin regulation). Any subcutaneous site (abdomen preferred) provides equivalent absorption and distribution. BPC-157 benefits from local injection near the injury; TB-500 does not require this.
How long does the loading phase need to be?
Most protocols use a 4–6 week loading phase at 2 mg 2x weekly (total 16–24 mg). Shorter loading (4 weeks) is appropriate for mild injuries; 6 weeks for chronic or severe injuries. After loading, the maintenance dose of 2 mg every 2 weeks sustains therapeutic tissue levels.
Can TB-500 and BPC-157 be used simultaneously?
Yes — this is one of the most common peptide combinations in injury recovery. BPC-157 provides local angiogenic and FAK-mediated repair, while TB-500 provides systemic stem cell mobilization and actin-cytoskeletal support. Use separate syringes; inject at separate abdominal sites or on the same or alternating days.
Is TB-500 WADA-prohibited?
Yes — Thymosin Beta-4 and its fragments are listed under WADA S2 (Peptide Hormones, Growth Factors, Related Substances). The peptide is detectable in plasma for approximately 24–48 hours after subcutaneous injection using LC-MS/MS methods.

Related protocols

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.